Exploring FNDC4 as a biomarker for prognosis and immunotherapy response in lung adenocarcinoma
Shengshan Xu(Jiangmen Central Hospital), Zhuming Lu(Jiangmen Central Hospital)
Cited by 31
Related Papers
Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response
|BMC Cancer|2024|50
The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis
|Journal of Inflammation Research|2025|48
Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer
|Frontiers in Immunology|2024|45